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Available online 21 June 2011Abstract Hypoxia is one way of inducing differentiation due to the activation of the key regulatory factor, Hypoxia-inducible
factor 1 alpha (HIF-1α). However, the action of HIF-1α on the differentiation of hESCs was unclear until now. To investigate the
effect of hypoxia on the differentiation of hESCs, we compared the differentiation efficacy into vascular lineage cells under
normoxic and hypoxic conditions. We observed HIF-1α expression and the related expression of pro-angiogenic factors VEGF, bFGF,
Ang-1 and PDGF in hEBs cultured under hypoxic conditions. Along with this, differentiation efficacy into vascular lineage cells was
improved under hypoxic conditions. When HIF-1α was blocked by echinomycin, both angiogenic factors and the differentiation
efficacywere down-regulated, suggesting that the enhancement of differentiation efficacywas caused by intrinsic up-regulation of
HIF-1α and these pro-angiogenic factors under hypoxic condition. This response might be primarily regulated by the HIF-1α signal
pathway, and hypoxia might be the key to improving the differentiation of hESCs into vascular lineage cells.
Therefore, this study demonstrated that microenvironmental changes (i.e., hypoxia) can improve differentiation efficacy of
hESCs into a vascular lineage without exogenous factors via cell-intrinsic up-regulation of angiogenic factors. These facts will
contribute to the regulation of stem cell fate.
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174 J.M. Shin et al.IntroductionHuman embryonic stem cells (hESCs), which are derived from
the inner cell mass of blastocysts, exhibit unique features
including pluripotency, self-renewal and the capacity to
differentiate into three germ layers both in vitro and in vivo
(Thomson et al., 1998).
Several previous studies were able to differentiate hESCs
into vascular lineage cells through marker sorting, growth
factor treatment, gene modification, enzyme treatment
or a specific isolation method (Levenberg et al., 2002; Wang
et al., 2007; Levenberg et al., 2007, n.a.; Ferreira et al.,
2007; Goldman et al., 2009; James et al., n.a.). In our
previous study, we were able to acquire a high yield of
endothelial like cells through isolation of the center region
of attached hEBs; the differentiation efficacy of these cells
was about 6 times higher than that of non-isolated cell
populations that existed in the out-growth region of
attached hEBs. Also, we verified that the expression of the
endothelial cell marker, PECAM (also known as CD31), was
restricted to the center region of attached hEBs (Kim et al.,
2007; Cho et al., 2007).
Therefore, we hypothesized that a hypoxic condition
existed in the center region of hEBs that could be more
permissive for differentiation of hEBs into vascular lineage
cells. Consequently, this study focuses on using hypoxia to
enhance the differentiation efficiency of hESCs into vascular
lineage cells.
Hypoxia is a low oxygen (O2) tension (1–5%) that can be an
important determinant for the differentiation and develop-
ment of many cells and tissues (Huang et al., 1996; Cameron
et al., 2008). The effect of hypoxia on the differentiation of
hESCs into vascular lineage cells is demonstrated in several
research groups (Prado-Lopez et al., n. a.; Ramirez-Bergeron
et al., 2004).
However, the exact mechanism of the effect of hypoxia
and HIF-1α is still not fully proven. To figure out the cause of
effect of hypoxia on the differentiation of hESCs into
vascular lineage cells, we hypothesized that the effect
could be regulated by combinational effect of HIF-1α
signaling and the pro-angiogenic factors which exist on the
HIF-1α downstream.
Cells and organs need to adapt to their microenviron-
ment, so it would not be surprising to find that a significant
number of the HIF-1 target genes are regulated in a tissue
specific manner. Decreased O2 levels activate HIF-1 and
induce approximately one hundred HIF-1 downstream genes
that affect various cellular functions including glycolysis,
glucose transport, erythropoiesis, and angiogenesis (Ke,
2006; Ramirez-Bergeron and Simon, 2001). HIF-1 activates
the expression of these genes by binding to a 50 base pair cis-
acting hypoxia response element (HRE) located in the
enhancer and promoter regions of these genes. Moreover,
using DNA microarrays, it has recently been reported that
more than 2% of all human genes are regulated by HIF-1 in
arterial endothelial cells, directly or indirectly (Huang et al.,
1996; Wang et al., 1995).
Angiogenesis is a complex process that involves multiple
gene products expressed by different cell types, and many
genes involved in different steps of angiogenesis are directly
or indirectly regulated by hypoxia. These include, but are notlimited to, vascular endothelial growth factor (VEGF), basic
fibroblast growth factor (bFGF), platelet-derived growth
factor (PDGF) and angiopoietin-1 (Plate et al., 1994; Ferrara,
2000).
Among these factors, VEGF is the most potent endothelial-
specific mitogen, and it directly participates in angiogenesis
by recruiting endothelial cells into hypoxic and vascular areas
and stimulating their proliferation. Therefore, the induction
of VEGF and other pro-angiogenic factors leads to an increase
in vascular density and hence decreases in oxygen diffusion
distance (Ke, 2006; Ferrara, 2000; Veikkola et al., 2000;
Jensen et al., 2006).
In normoxic conditions, the HIF-1α proteins are rapidly
degraded, resulting in essentially no detectable HIF-1α
protein. During hypoxia, HIF-1α becomes stabilized and
translocates from the cytoplasm to the nucleus, where it
dimerizes with HIF-1β and the HIF complex becomes
transcriptionally active. The stability and activity of the α
subunit of HIF are regulated by post-translational modifica-
tions such as hydroxylation, ubiquitination, acetylation, and
phosphorylation (Ke, 2006; Wang et al., 1995; Ohh et al.,
2000).
Activation of HIF activity has also been demonstrated in
physiological responses to ischemic, hypoxic and inflamma-
tory conditions, where it plays a positive role in the tissue or
organ's ability to respond to damage. For example, the levels
of HIF-1α and VEGF were increased in the myocardium of
patients when these patients developed acute coronary
artery occlusion. Effective vascular remodeling following
ischemic injury depended on an integrated program of HIF-
dependent gene expression. An increase in the expression of
HIF-1α and HIF-inducible genes was also observed in sheep
and rat models of myocardial and cerebral ischemia. In
addition, the induction of HIF-1α or HIF-2α and their target
genes has been shown in the pre-eclamptic placenta, by
macrophages in rheumatoid synovia, in the ischemic retina
and as a result of wound healing (Horowitz, 2010; Chi and
Karliner, 2004; Wu et al., n.a.; Zhou et al., n.a.; Rajakumar
et al., 2003; Hollander et al., 2001; Zhu et al., 2007; Zhang
et al., n.a.).
Echinomycin (also known as NSC-13502) has recently been
used as a strong HIF-1α inhibitor that acts by blocking HIF-1
DNA binding and transcriptional activity. Also, echinomycin
inhibits the binding of HIF-1 to the endogenous HRE of the
VEGF (Low et al., 1986; May et al., 2004; Kong et al., 2005;
Vlaminck et al., 2007).
Here, we investigated the effect of hypoxia on the
differentiation efficiency of hESCs into vascular lineage
cells, mediated by HIF-1α activation and the release of
several angiogenic factors such as VEGF, bFGF, Ang-1 and
PDGF from hEBs. The release of pro-angiogenic factors from
hEBs was increased under hypoxic conditions and the
differentiation efficiency of hESCs into vascular lineage
cells was also increased. When we treated hEBs cultured
under hypoxic conditions with echinomycin, the release
of pro-angiogenic factors and the differentiation efficiency
of hESCs were decreased to levels similar to those found
when hEBs are cultured under normoxic conditions.
This study confirmed the effect of hypoxia on the
differentiation of hESCs into vascular lineage cells via
activation of HIF-1α and up-regulation of pro-angiogenic
factor secretion.
175Enhancement of differentiation efficiency of hESCs into vascular lineage cells in hypoxiaResults
Enhancement of differentiation efficacy in hEBs
cultured under hypoxia
To compare the differentiation efficacy between normoxic
and hypoxic conditions, hEBs were cultured under normoxic
and hypoxic conditions and their differentiation efficacy was
analyzed using RT-PCR and FACs analyses (Fig. 1).Normoxia hEBs Hypoxia hEBsA
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176 J.M. Shin et al.conditions (Fig. 1A, lower). Also, using Annexin V expression
measured by FACS, apoptotic cells were observed at a rate of
1.33% and 7.04% under normoxic and hypoxic conditions,
respectively. These results show that hypoxia does not induce
massive apoptosis in cultured hEBs, although apoptosis was
higher in hypoxic conditions than in normoxic conditions
(Supplemental Fig. 1).
Next, to compare differentiation efficacy, we performed
RT-PCR and FACS analyses and immunostaining for the
vascular related markers PECAM, KDR (also known as VEGF
receptor-2), CD144 (also known as VE-cadherin), FLT-1 and
Tie-2 (also known as Angiopoietin-1 receptor) at day 10 in
hEBs cultured under both conditions (Figs. 1B–D).
As measured by RT-PCR analysis, undifferentiated stage
markers, such as Oct-4, Nanog and Sox 2, were expressed in
hEBs cultured under both conditions. When compared with
naïve hESCs, the expression was similar with hEBs cultured
under normoxic condition, but the expressionwas lower in hEBs
cultured under hypoxic conditions than those under normoxic
conditions and naive hESCs. Conversely, the expression of
vascular lineage markers PECAM, KDR, CD144 and Tie-2 was1.5–2.5 fold higher in hEBs cultured under hypoxia conditions
than those cultured under normoxic conditions (Figs. 1B and C).According to FACS analysis, the expression of the other
vascular-related markers such as Flt-1, Tie-2, KDR, CD144
and PECAM was 19.29%, 33.92%, 50.96%, 33.56% and 27.77%
in hEBs cultured under hypoxic conditions, respectively, and
the expression of each of these markers was about 5–22%
higher than in hEBs cultured under normoxic conditions
(Fig. 1D and Supplementary Fig. 3).
Moreover, we performed immunostaining with PECAM and
vWF to compare endothelial cell location and vessel like
structure in hEBs cultured under normoxic and hypoxic
conditions. PECAM and vWF are expressed cell membrane
and cell cytoplasm, respectively. To induce further differen-
tiation and confirm the PECAM and vWF positive cell
population using immunostaining, we attached hEBs on
Matrigel and allowed cells in the periphery of hEBs to migrate
outward in both normoxic and hypoxic conditions.
PECAM positive cells (red) were largely found in hEB
clusters cultured under hypoxic condition and spontaneously
formed vessel-like structures (Fig. 1E, left lower panel). On
177Enhancement of differentiation efficiency of hESCs into vascular lineage cells in hypoxiathe other hand, PECAMpositive cells (red)were rarely found in
hEBs cultured under normoxic condition (Fig. 1E, left upper
panel). Similar with PECAM immunostaining result, vWF
positive cells (green) were broadly distributed in hEB clusters
cultured under hypoxic condition (Fig. 1E, right upper panel).
Although, vWF positive cells (green) were also observed in
several portions of hEBs cultured under normoxic condition
(Fig. 1.E, right lower panel), but the vWF positive cell
population was distributed more distinctly and shown more
convincing positive expression pattern in hEBs cultured under
hypoxic condition.
Then, we calculated number and length of sprouted
branch using image analysis program; image J, to quantify of
vasculogenic potential through more direct method (Fig. 1F).
As same as immunostaining, we attached hEBs on Matrigel
and allowed cells in the periphery of hEBs to migrate
outward, then we calculated number and length of sprouted
branch for quantification. The sprouting EB model was used
to assess embryonic vasculogenic outgrowth of vascular
development in mouse ES cells (Feraud et al., 2001) and in
human ES cells (Levenberg et al., 2002).
In sprouting structure, the sprouted branches were
emerged from the initial primitive endothelial structures
which were shown in attached hEBs, and then gave rise to an
endothelial network. After cultivation on Matrigel for 72 h,
sprouts from individual hEBs grew to connect and form
vascular network-like structures (Fig. 1F, left panel). When
compared with attached hEBs cultured under normoxic and
hypoxic conditions, the number and length of sproutedNormoxia HIF-1 DAPI
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Our study demonstrated that the hypoxic condition
promoted the differentiation efficacy of hESCs which was
proved by enhanced vascular lineage marker expression and
forming sprouted outgrowth structures.The expression of HIF-1α and candidate angiogenic
factors in hEBs cultured under normoxic and
hypoxic conditions
Next, we examined the expression of HIF-1α and candidate
angiogenic factors VEGF, bFGF, Ang-1 and PDGF in hEBs
cultured under normoxic and hypoxic conditions (Fig. 2).
To determine the HIF-1α expression in hEBs cultured under
normoxic and hypoxic conditions, we performed immunostain-
ing and Western blot analysis. As measured by immunostaining,
HIF-1α (red) was rarely observed under normoxic conditions,
and the translocation of HIF-1α into the nucleus was not
observed (Fig. 2A, upper). On the other hand, in hypoxic
conditions, HIF-1α (red) was observed in most of the cells
comprising the hEBs, and nuclear translocation of HIF-1α was
also observed (Fig. 2A, lower). HIF-1α becomes stabilized and
translocates from the cytoplasm to the nucleus, where it
dimerizes with HIF-1β. Only then does the HIF complex become
transcriptionally active, so the translocation of HIF-1α is an
important measure to determine the functional activity of the
complex.-actin
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178 J.M. Shin et al.Because functionally activated HIF-1α can regulate
downstream genes that are involved in angiogenesis, we
compared the downstream angiogenesis-related proteins
VEGF, bFGF, Ang-1 and PDGF-BB with HIF-1α expression
using Western blot analysis (Figs. 2B and C).
As measured by Western blot analysis, increased expres-
sion of HIF-1α and its downstream target proteins, such as
VEGF, bFGF, Ang-1 and PDGF-BB, was verified in hEBs
cultured under hypoxic conditions (Fig. 2B). Under normoxic
conditions, the HIF-1α proteins are rapidly degraded (refer),
resulting in essentially no detectable HIF-1α proteins.
Therefore, we treated hEBs with MG132 (4 uM) for 1.5 h
before preparation of cell pellets to protect against protein
degradation. MG132 is a selective proteasome inhibitor and
blocks degradation of short lived proteins.
Whether treated with MG132 or not, hEBs cultured under
hypoxic conditions had higher HIF-1α expression than hEBs
cultured under normoxic conditions, but it was difficult to
detect HIF-1α expression without treating with MG132
(Fig. 2B). When comparing the expression level of candidate
angiogenesis related genes under normoxia and hypoxia, we
found that these genes were significantly increased in hEBs
cultured under hypoxia; their expression correlated with
increased HIF-1α expression and their expression was higher
in the MG132-treated group. When we quantified the Western
blot signals, we determined that HIF-1α expression in hypoxic
conditions was about 2 fold higher than under normoxicR
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released by hEBs cultured under normoxic and hypoxic conditions.conditions and the expression of VEGF, bFGF, Ang-1 and PDGF-
BB was 1.2–2.5 fold higher in hypoxia compared to normoxia,
with and without treatment with MG132 (Fig. 2C).Confirmationof up-regulated angiogenic related factor
expression under hypoxic conditions
To confirm the genomic expression level and secretion of
angiogenic factors, we performed real-time PCR and
quantitative immunoassays (ELISA).
According to real time PCR analysis, HIF-1α expression
was about 2.5 times higher in hEBs cultured under hypoxic
than under normoxic conditions, and the relative value of
candidate angiogenic factors VEGF, bFGF, Ang-1 and PDGF
was about 2.8, 1.5, 1.7 and 1.6 times higher in hypoxic hEBs
than in normoxic hEBs, respectively (Fig. 3A). In agreement
with Western blot results, the up-regulated expression of
candidate angiogenic factors was correlated with up-
regulated HIF-1 α expression under hypoxic conditions, as
measured by real-time PCR analysis.
With this, the expression of receptors for candidate
angiogenic factors bFGF, VEGF, Ang-1 and PDGF also up-
regulated in hypoxic hEBs (Fig. 3B).
The secretion of angiogenic factors into the cell culture
supernatant of hEBs was measured by ELISA (Fig. 3C). DMEM/
F-12 containing 10% knockout SR, the basal medium for hEB1
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factors. The secretion of VEGF, bFGF, Ang-1 and PDGF-BB was
about 9-fold (9.5 pg/mL in hypoxic conditions), 1.8-fold
(36 pg/mL in hypoxic conditions), 1.2-fold (6.7 pg/mL in
hypoxic conditions), and 1.7-fold (4.2 pg/mL in hypoxic
conditions) higher in the supernatant of hypoxic hEBs
compared to normoxic hEBs (Fig. 3C).
According to Western blotting, real time PCR and ELISA,
angiogenic-related factors and their receptors were up-
regulated under hypoxic conditions, as was HIF-1α expres-
sion. Of the angiogenic-related factors, VEGF, which is the
most well-known HIF-1α dependent angiogenic related
factor, was the most increased by hypoxia.
All experiments were repeated three times and the quanti-
tative data were obtained from three repeated experiments.
Expression of HIF-1α and candidate angiogenic
factors after treating with echinomycin under
normoxic and hypoxic conditions
hEBs were incubated for 12 h under hypoxia or normoxia in the
presence or absence of echinomycin (20 nM). As described by
Kong et al. (Huang et al., 1996), echinomycin is a strong HIF-1
inhibitor that acts by inhibiting HIF-1 DNA binding capacity and
hence transcriptional activity. Echinomycin influenced hypoxia-
induced HIF-1 accumulation.
We performed real-time PCR and Western blot analysis to
examine whether echinomycin prevented the increased
expression of HIF-1α and candidate angiogenesis related
genes under hypoxia (Fig. 4).
To determine whether inhibition of HIF-1α affected the
expression of candidate angiogenic factors, we first investi-
gated gene expression between normoxic and hypoxic hEBs
with or without echinomycin treatment. As measured by real-
time PCR analysis, HIF-1α expression was down-regulated by
echinomycin in both normoxic and hypoxic conditions.
Expression levels of candidate angiogenesis related factors
were also down-regulated by echinomycin in both normoxic
and hypoxic conditions (Fig. 4B).
To confirm the expression pattern of HIF-1α and
candidate angiogenesis related factors, we examined the
protein levels of these factors under hypoxic conditions with
or without echinomycin and quantified the results using an
imaging analysis system (Figs. 4C and D).
HIF-1α was down-regulated about 2-fold, and VEGF,
bFGF, Ang-1 and PDGF-BB were down-regulated about 1.5–
2.5-fold by treatment with echinomycin.
We next used FACs analysis tomeasure the influence of HIF-
1α inhibition on the differentiation of hypoxic hEBs into
vascular lineage cells.Weobserved that the expression of Flt-1
(1.94%), Tie-2 (8.60%), KDR (5.81%), CD144 (2.66%) and PECAM
(1.34%) was decreased 6–75% by echinomycin (Fig. 4E).
Enhanced vasculogenic differentiation efficacy
through treating angiogenesis related factor
on hEBs
The enhanced differentiation efficacy in hypoxic hEBs resulted
from the up-regulation of angiogenesis related factors, and
VEGF and bFGF were the most increased of these factors.
Therefore, to confirm the effect of VEGF and bFGF on thedifferentiation of hEBs into vascular lineage cells, we cultured
hEBs under normoxia and treated cells with 50 ng VEGF or
100 ng bFGF for 10 days. According to FACS analysis, expres-
sion levels of the vascular related proteins FLT-1, Tie-2, KDR,
CD144 and PECAM were increased when compared with
normoxic hEBs not given VEGF or bFGF.
The relative values of FLT-1 (21%), Tie-2 (30.80%), KDR
(48.88%), CD144 (11.67%) and PECAM (12.42%) were 1.2–2.4
times higher, respectively, in hEBs treated with bFGF than in
control hEBs (Fig. 5A, middle panel).
Moreover, relative values of FLT-1 (29.73%), Tie-2 (31.40%),
KDR (52.50%), CD144 (11.10%) and PECAM (15.12%) were about
1.2–3.4 times higher, respectively, in hEBs treated with VEGF
than control hEBs (Fig. 5A, lowest panel).
Also, in immunostaining of attached hEBs treating bFGF and
VEGF analysis, we could observed that PECAM (red) positive
cell population were largely existed in hEBs treating bFGF and
VEGF and spontaneously formed vessel-like structures, as
similar as hEBs cultured under hypoxic condition (Fig. 5B).
Then, to compare the vasculogenic capacity after treating
bFGF and VEGF through more direct method, we also
performed sprouting assay on Matrigel. As similar with
Fig. 1F, sproutedbranches from attached hEBs grew to connect
and form vascular network-like structures (Fig. 5C, left panel).
When compared with attached hEBs cultured under normoxic
condition, there was no significant increase of the sprouted
capillary number following bFGF and VEGF treatment. How-
ever, bFGF and VEGF treatment increased the sprouted
capillary length about 2.1 and 2.5 times, respectively, than
control normoxic cultured hEBs (Fig. 5C, right panel).
Therefore, we conclude that the addition of bFGF or
VEGF, which is the most up-regulated angiogenic factors
under hypoxic conditions, directly promotes the vascular
lineage differentiation of hEBs.Discussion
Oxygen sensing is vital for proper cardiovascular formation,
and oxygen tension is likely an important determinant of
hematopoietic and endothelial cell production (Cameron
et al., 2008). Several groups have already reported that
hypoxia, defined as low oxygen tension (1–5% O2), affects
mesodermal and hemangioblast lineage specification during
early embryogenesis (Ramirez-Bergeron et al., 2004; Adelman
et al., 1999; Fehling et al., 2003). In our previous study, the
PECAM-positive endothelial cell population was mainly re-
stricted to the center region of attached hEBs and the
efficiency of differentiation of these cells into endothelial
cells was about 6 times higher than in cells from the outgrowth
region of attached hEBs (Kim et al., 2007). We hypothesized
that hypoxia, which existed in the center region of hEBs, could
be a key inducer of differentiation, and consequently, we
investigated here the effect of hypoxia on the differentiation
of hESCs into vascular lineage cells. Furthermore, this study
provides insight into the release of several angiogenic factors,
which could improve the vascular lineage differentiation of
hypoxic hEBs.
In this study, we cultured hEBs under normoxic and
hypoxic conditions and compared their efficiency of differ-
entiation into vascular lineage cells and their up-regulation
and secretion of angiogenesis related factors.
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Figure 4 Effect of echinomycin on hEBs under normoxic and hypoxic conditions. (A) Morphology of hEBs under normoxic and hypoxic
conditions in the presence or absence of echinomycin. Scale bar; 50 μm. (B) Real time PCR analyses of HIF-1α and candidate
angiogenic factors such as VEGF, bFGF and Ang-1 in hEBs under normoxic and hypoxic conditions in the presence or absence of
echinomycin (n=3). (C) Western blot analysis of HIF-1α, VEGF, bFGF, Ang-1 and PDGF.BB in hEBs under normoxic and hypoxic
conditions in the presence or absence of echinomycin. (D) Protein expression was measured by scanning and the TINA analysis
program. (E) Flow cytometric analysis of hEBs after treating echinomycin, demonstrating the inhibition of the endothelial lineage
differentiation by echinomycin treatment, defined by decreased expression of Flt-1, Tie-2, KDR, CD144 and PECAM.
180 J.M. Shin et al.Before performing experiments, we examined chromo-
some stability and apoptosis induction because hypoxia is a
stressful condition for cells; we found normal chromosomal
stability and only a small increase in apoptosis induction in
our hEBs as a result of hypoxia.
In immunostaining analysis of hEBs, PECAM- and vWF-
positive cells of normoxic hEBs were restricted and did not
show clear structure and population, whereas PECAM- and
vWF positive cells in hypoxic hEBs were distributed through-
out the whole body, including the outgrowth region.
However, quantification of this change was difficult, so we
verified the enhanced vascular lineage differentiation under
hypoxia using qRT-PCR and FACs analyses.
Vascular lineage markers (Flt-1, Tie-2, KDR, CD144 and
PECAM) were increased in hypoxic hEBs, and these findings
again confirmed that oxygen tension is likely an important
determinant of vascular lineage cell production.To investigate whether hypoxia activates HIF-1α and
downstream pro-angiogenic genes, we performed qRT-PCR,
Western blot, immunocytochemistry and ELISA assays to
detect the expression of HIF-1α and vascular related pro-
angiogenic genes (VEGF, bFGF, Ang-1 and PDGF).
To be functionally active, HIF-1α must translocate to the
nucleus, dimerize with ARNT and transactivate hypoxia-
responsive genes by binding to hypoxia response elements
(HREs) located in the promoter or enhancer regions of hypoxia-
inducible genes (Ramirez-Bergeron et al., 2004). Here, via
immunostaining, we verified the translocation of HIF-1α into
the nucleus by hypoxia. Also, we found that the expression of
HIF-1α and pro-angiogenic factors was increased by hypoxia.
Therefore, we conclude that representative pro-angiogenic
factors, such as VEGF and bFGF, are downstream of HIF-1α
signaling. Also, up-regulated VEGF expression could act as a
survival factor for hypoxic hEBs because VEGF165 is a known
181Enhancement of differentiation efficiency of hESCs into vascular lineage cells in hypoxiasurvival factor for ES cells under hypoxic conditions and can
prevent apoptosis in response to both short- (b24 h) and long-
term (N24 h) hypoxia (Levenberg et al., 2007). This fact
suggests that the lack ofmassive apoptosis in hypoxic hEBsmay
be due to up-regulated VEGF expression.
To further investigate the effect of hypoxia on the
differentiation of hESCs, we treated cells with echinomycin,
a representative HIF-1α inhibitor. Before testing the effect
of echinomycin, we optimized the concentration of echino-
mycin through several pilot studies; we determined that
20 nM for 12 h was the optimal dose to avoid cytotoxicity and
cell cycle arrest. We found that echinomycin blocked the
expression of HIF-1α and downstream pro-angiogenic factor
and down-regulated vascular lineage differentiation. This
result suggests that hypoxia enhances vascular lineage
differentiation by up-regulating HIF-1α and angiogenic
factor expression.B
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182 J.M. Shin et al.We treated normoxic hEBs with commercially available VEGF
or bFGF for 10 days to induce differentiation. Treating hEBs
with VEGF or bFGF increased differentiation into vascular
lineage cells to the same extent as hypoxia. These results
clearly demonstrate that addition of VEGF or bFGF during hESC
differentiation promotes vascular lineage cell development,
even in normoxic conditions. The roles of VEGF and bFGF
during hESC differentiation are already well known; however,
we have not only confirmed the direct effect of VEGF and bFGF
treatment on the differentiation of hESCs but also confirmed
that up-regulation of VEGF and bFGF by hypoxia permitted
vascular lineage differentiation.
Themost well-studied angiogenic factor that is regulated by
hypoxia is VEGF; hypoxic induction of an HIF-1-dependent bFGF
autocrine loop drives angiogenesis, over-expression of Ang-1
causes a significant increase in HIF-1 stabilization and PDGF-BB
participates in anautocrine-paracrine survival pathway (Jensen
et al., 2006; Chen, 2008; Karakiulakis et al., 2007; Zhang et al.,
2003).Conclusion
In summary, this study demonstrated, for the first time, a
method to improve the development of vascular lineage cells
from hESCs via the up-regulation of HIF-1 and downstream
angiogenic factors by hypoxia.
Thus, these results suggest that hypoxia could promote
the derivation of vascular lineage cells in vitro and that these
cells could be a valuable novel cell source for regenerative
medicine.Material and methods
hESC culture, hEB formation and differentiation
The undifferentiated hESCs (CHA-hESC 3) were cultured on
mitotically inactivated STO feeder cells (ATCC, Manassas,
VA) in DMEM/F12 (50:50; Gibco BRL, Gaithersberg, MD)
supplemented with 20% (v/v) serum replacement (Gibco)
and basic ES medium components including 1 mM L-gluta-
mine (Gibco), 1% nonessential amino acids (Gibco), 100 mM
beta mercaptoethanol (Gibco), and 4 ng/mL bFGF (Sigma,
St. Louis, MO). Every 5 or 6 days, hESCs were detached with adissecting pipette and transferred to new dishes with
mitomycin C-treated STO feeder cells, as previously de-
scribed (Cho et al., 2007). For formation of hEBs, hESCs were
detached from feeder cells by Dispase (Gibco) and cultured
in suspension in DMEM/F12 (50:50; Gibco) supplemented
with 10% (v/v) serum replacement (Gibco) and basic ES
medium components including 1 mM L-glutamine (Gibco), 1%
nonessential amino acids (Gibco), and 100 mM beta mercap-
toethanol (Gibco) without bFGF treatment, under normoxic
conditions (21% O2 tension) for 10 days. To culture hEBs
under hypoxic conditions (3% O2 tension), hEBs were
transferred to hypoxic condition 3 days after hEB formation
and incubated in a 3% O2 incubator for an additional 7 days in
samemedium condition of normoxic condition cultured hEBs.
For treatment with VEGF and bFGF, hEBs were cultured in
suspension in same medium condition of normoxic condition
cultured hEBs, supplemented with 50 ng VEGF and/or 100 ng
bFGF for 10 days.
RNA extraction and real-time quantitative RT-PCR
Total RNA was isolated from hEBs cultured under normoxia or
hypoxia in the presence or absence of echinomycin (Bioaus-
tralis, Australia) using Trizol reagent (Invitrogen). One
microgram of RNA was reverse-transcribed into cDNA. Real-
time quantitative RT-PCR primers were targeted to HIF-1α
and candidate angiogenesis related genes (VEGF, bFGF,
angiopoietin-1 and PDGF). Quantification of genes was
performed using SyBr Green gene expression assays (Eppen-
dorf Realplex 2, Germany). PCR amplification was generated
using gene-specific primers (Table 1).
The level of target gene expression was determined by the
comparative Ct method, whereby the target is normalized
to endogenous β-actin. The Ct value is the cycle number at
which the fluorescence level reaches threshold. The ΔCt is
determined by subtracting the Ct of theβ-actin control fromCt
of target gene [ΔCt=Ct (target)–Ct (β-actin)]. This relative
value of target to endogenous reference is described as the
fold of β-actin=2−ΔCt.
Western blot analysis
After separation by 6–12% SDS-polyacrylamide gel electro-
phoresis (PAGE), proteins (50 μg) were transferred to
Table 1 Real-time PCR primers.
Genes Sense/antisense 5′——————————————————————→3′
HIF-1α Sense AAGTTCACCTGAGCCTAATAGTCC
Antisense GGGTTCTTTGCTTCTGTGTCTTC
VEGF Sense CGCTTACTCTCACCTGCTTCTG
Antisense CTGTCATGGGCTGCTTCTTCC
bFGF Sense TTCAGTCTTCGCCAGGTCATTG
Antisense GCCGCCTAAAGCCATATTCATTC
Angiopoietin-1 Sense CCGTGAATCTGGAGCCGTTTG
Antisense AAGCCCGACAGTCAGTGGAG
PDGF.AA Sense TCGGGAAGAGGACACGGATG
Antisense TTTCACGGAGGAGAACAAAGACC
PDGF.BB Sense TGCTGTTGAGGTGGTGTAGATG
Antisense GGTGGAGGTAGAGAGATGAAAGG
U6 Sense CTCGCTTCGGCAGCACA
Antisense AAGCTTCACGAATTTGCGT
183Enhancement of differentiation efficiency of hESCs into vascular lineage cells in hypoxiapolyvinylidenedifluoride (PDVF) membranes (Bio-Rad). Mem-
branes were blocked for 1 h in 5% non-fat milk in Tris-buffered
saline (TBS) containing 0.05% Tween 20 (TTBS) and incubated
with primary antibody for 4 h at room temperature. After
being washed in TTBS, membranes were incubated for 1 h at
room temperature with peroxidase-labeled secondary anti-
bodies. The membrane was then scanned, and the signal
intensity of each band was determined using an LAS 3000 (Fuji
Photo Film Co., Ltd). Relative protein levels in each sample
were then normalized to β-actin.
Concentrations of primary antibodies were as follows:
HIF-1α (1:1000, Chemicon), VEGF (1:1000, R&D); bFGF
(1:500, R&D); PDGF.BB (1:500, Chemicon) and β-actin
(1:2000, Sigma).Immunocytochemistry
The hEBs cultured under normoxia and hypoxia were
attached on Matrigel for 48 h and then fixed in 4%
paraformaldehyde for 30 min and permeabilized with 0.1%
Triton X-100 in phosphate-buffered saline (PBS) for 5 min.
After treatment with 3% BSA for 1 h at room temperature,
the cells were incubated with primary antibody against
PECAM (BD Bioscience, San Diego, CA), vWF (BD Bioscience)
and HIF-1α (Abcam, Cambridge, UK) for 4 h at room
temperature. Cells were washed with PBS and then
incubated with a rhodamine- and FITC-conjugated secondary
antibody (Molecular Probes Inc., Eugene, OR) for 2 h 30 min.
After being washed with PBS, cells were stained with 4,6-
diamidino-2 phenylindole (DAPI) for 5 min. Fluorescence was
examined using a LSM510 META confocal microscope (Carl
Zeiss Inc., Oberkochen, Germany).Flow cytometry
For FACS analysis, hEBs cultured under normoxia and hypoxia
in the presence or absence of echinomycin were dissociated
with 0.25% Trypsin–EDTA (Gibco) and washed with PBS
containing 2% (vol/vol) fetal bovine serum (FBS). They were
incubated with either isotype control or antigen-specific
antibodies for 20 min: FLT-1-PE, Tie-2-APC, KDR-APC,CD144-PE and PECAM-PE (All provide from R&D systems,
Minneapolis, MN). Propidium iodide staining (5 ng/mL) was
used to identify nonviable cells. FACS analysis was performed
using a FACS Caliber FlowCytometer (BD Bioscience) and
analyzed using CellQuest Pro (BD Bioscience).
ELISA assay
To compare the expression level of pro-angiogenic factors
released from hEBs cultured under normoxic and hypoxic
conditions, hEBs cultured under normoxic and hypoxic
conditions were plated with equal cell numbers. Then,
media were collected and concentrated to 25×. Levels of
secreted VEGF, bFGF, angiopoietin-1 and PDGF.BB in the
concentrated conditioned media were measured by ELISA
(R&D systems).
Capillary sprouting assay on Matrigel
Analysis of vessel formation in vitro is performed through 3D
culture of cells on Matrigel.
After formation and culture of hEBs for 7 days in several
condition (normoxic and hypoxic conditions, bFGF and VEGF
treated condition), hEBs were plated on Matrigel and
subjected to further culture for 72 h. 0.2 mL of Matrigel
(BD Bioscience) was solidified at 37 °C for 30–40 min in glass-
bottom culture plates. For induction of vascular formation,
0.1 mL of cell suspension containing individual 40 hEBs was
plated on top of the Matrigel. Samples were incubated at
37 °C for 72 h and analyzed for the formation of capillary-
like structures and observed by phase-contrast microscopy.
For analyzing and quantification of number and length of
sprouted branches, each sprouted branch was measured by
Image J (version 6.0; NIH).
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